Vaxxinity, Inc.
VAXX
$0.0002
-$0.0153-98.71%
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -56.06% | -24.18% | -7.29% | 10.44% | -74.57% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -44.05% | -31.99% | -16.24% | 3.55% | -56.39% |
| Operating Income | 44.05% | 31.99% | 16.24% | -3.55% | 56.39% |
| Income Before Tax | 44.31% | 31.72% | 18.98% | -0.87% | 57.25% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 44.31% | 31.72% | 18.98% | -0.87% | 57.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 44.31% | 31.72% | 18.98% | -0.87% | 57.25% |
| EBIT | 44.05% | 31.99% | 16.24% | -3.55% | 56.39% |
| EBITDA | 44.81% | 33.96% | 17.41% | -2.19% | 57.37% |
| EPS Basic | 44.86% | 32.09% | 19.34% | -0.55% | 65.97% |
| Normalized Basic EPS | 44.77% | 32.15% | 19.28% | -0.55% | 65.98% |
| EPS Diluted | 44.86% | 32.09% | 19.34% | -0.55% | 65.97% |
| Normalized Diluted EPS | 44.77% | 32.15% | 19.28% | -0.55% | 65.98% |
| Average Basic Shares Outstanding | 0.92% | 0.56% | 0.42% | 0.28% | 25.62% |
| Average Diluted Shares Outstanding | 0.92% | 0.56% | 0.42% | 0.28% | 25.62% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |